IPF2α-I: An index of lipid peroxidation in humans

作者: D. Pratico , O. P. Barry , J. A. Lawson , M. Adiyaman , S.-W. Hwang

DOI: 10.1073/PNAS.95.7.3449

关键词:

摘要: Isoprostanes are prostaglandin isomers produced from arachidonic acid by a free radical-catalyzed mechanism. Urinary excretion of 8-iso-prostaglandin F2α, an isomer the PGG/H synthase (cyclooxygenase or COX) enzyme product, F2α (PGF2α), has exhibited promise as index oxidant stress in vivo. We have developed quantitative method to measure isoprostane F2α-I, (IPF2α-I) class I (8-iso-PGF2α is IV), using gas chromatography/mass spectrometry. IPF2α-I severalfold abundant human urine 8-iso-PGF2α, with mean values 737 ± 20.6 pg/mg creatinine. Both isoprostanes formed radical-dependent manner low density lipoprotein oxidized copper vitro. However, IPF2α-I, unlike not COX-dependent platelets activated thrombin collagen Similarly, COX inhibition vivo no effect on IPF2α-I. Neither serum cellular capacity generate isoprostane, nor urinary actual generation vivo, depressed aspirin indomethacin. In contrast, both thromboxane B2 and its 11-dehydro metabolite inhibitors. Although 8-iso-PGF2α formation substantially inhibitors, compound unaffected. elevated cigarette smokers compared controls (1525 180 versus 740 40 creatinine; P < 0.01) highly correlated (r = 0.9; 0.001). novel lipid peroxidation which can be measured precision sensitivity. It F2-isoprostane radical- but manner. may minor product COX, this pathway contributes trivially, if at all, levels urine. smokers.

参考文章(41)
Colin D. Funk, Lena B. Funk, Matthew E. Kennedy, Amy S. Pong, Garret A. Fitzgerald, Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. The FASEB Journal. ,vol. 5, pp. 2304- 2312 ,(1991) , 10.1096/FASEBJ.5.9.1907252
J.A. Awad, J.D. Morrow, K. Takahashi, L.J. Roberts, Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. Journal of Biological Chemistry. ,vol. 268, pp. 4161- 4169 ,(1993) , 10.1016/S0021-9258(18)53593-6
Felix Reutter, Hannsjörg W. Seyberth, Horst Schweer, Rolf M. Nüsing, Thomas Klein, Generation of the Isoprostane 8-Epi-prostaglandin F2α In Vitro and In Vivo via the Cyclooxygenases Journal of Pharmacology and Experimental Therapeutics. ,vol. 282, pp. 1658- 1665 ,(1997)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
C. Patrono, C. Creminon, J. Maclouf, J. Lawson, G. A. Fitzgerald, Zhaoyue Wang, G. Ciabattoni, Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. Journal of Pharmacology and Experimental Therapeutics. ,vol. 275, pp. 94- 100 ,(1995)
Domenico Pratico, John A. Lawson, Garret A. FitzGerald, Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α Journal of Biological Chemistry. ,vol. 270, pp. 9800- 9808 ,(1995) , 10.1074/JBC.270.17.9800
Jason D. Morrow, Tanya A. Minton, Kamal F. Badr, L.Jackson Roberts, Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivo Biochimica et Biophysica Acta. ,vol. 1210, pp. 244- 248 ,(1994) , 10.1016/0005-2760(94)90128-7
Aaron R. Folsom, Kenneth K. Wu, Wayne D. Rosamond, A. Richey Sharrett, Lloyd E. Chambless, Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. ,vol. 96, pp. 1102- 1108 ,(1997) , 10.1161/01.CIR.96.4.1102
M. Levine, C. Conry-Cantilena, Y. Wang, R. W. Welch, P. W. Washko, K. R. Dhariwal, J. B. Park, A. Lazarev, J. F. Graumlich, J. King, L. R. Cantilena, Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 3704- 3709 ,(1996) , 10.1073/PNAS.93.8.3704
Edgar R. Miller, Lawrence J. Appel, Long Jiang, Terence H. Risby, Association Between Cigarette Smoking and Lipid Peroxidation in a Controlled Feeding Study Circulation. ,vol. 96, pp. 1097- 1101 ,(1997) , 10.1161/01.CIR.96.4.1097